181 related articles for article (PubMed ID: 23377518)
1. Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa-infected wounds.
Chouake J; Schairer D; Kutner A; Sanchez DA; Makdisi J; Blecher-Paz K; Nacharaju P; Tuckman-Vernon C; Gialanella P; Friedman JM; Nosanchuk JD; Friedman AJ
J Drugs Dermatol; 2012 Dec; 11(12):1471-7. PubMed ID: 23377518
[TBL] [Abstract][Full Text] [Related]
2. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione.
Friedman AJ; Blecher K; Schairer D; Tuckman-Vernon C; Nacharaju P; Sanchez D; Gialanella P; Martinez LR; Friedman JM; Nosanchuk JD
Nitric Oxide; 2011 Nov; 25(4):381-6. PubMed ID: 21946032
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY; Friedman AJ
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
[TBL] [Abstract][Full Text] [Related]
4. The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections.
Mihu MR; Sandkovsky U; Han G; Friedman JM; Nosanchuk JD; Martinez LR
Virulence; 2010; 1(2):62-7. PubMed ID: 21178416
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-releasing chitosan film for enhanced antibacterial and in vivo wound-healing efficacy.
Kim JO; Noh JK; Thapa RK; Hasan N; Choi M; Kim JH; Lee JH; Ku SK; Yoo JW
Int J Biol Macromol; 2015 Aug; 79():217-25. PubMed ID: 25957720
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial photodynamic therapy on drug-resistant Pseudomonas aeruginosa-induced infection. An in vivo study.
Hashimoto MC; Prates RA; Kato IT; Núñez SC; Courrol LC; Ribeiro MS
Photochem Photobiol; 2012; 88(3):590-5. PubMed ID: 22404212
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial efficacy and toxicity of novel CAMPs against P. aeruginosa infection in a murine skin wound infection model.
Yang M; Zhang C; Hansen SA; Mitchell WJ; Zhang MZ; Zhang S
BMC Microbiol; 2019 Dec; 19(1):293. PubMed ID: 31842727
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection.
Martinez LR; Han G; Chacko M; Mihu MR; Jacobson M; Gialanella P; Friedman AJ; Nosanchuk JD; Friedman JM
J Invest Dermatol; 2009 Oct; 129(10):2463-9. PubMed ID: 19387479
[TBL] [Abstract][Full Text] [Related]
9. AB569, a Novel, Topical Bactericidal Gel Formulation, Kills Pseudomonas aeruginosa and Promotes Wound Healing in a Murine Model of Burn Wound Infection.
Barry A; Panmanee W; Hassett DJ; Satish L
Infect Immun; 2021 Oct; 89(11):e0033621. PubMed ID: 34424744
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition.
Han G; Nguyen LN; Macherla C; Chi Y; Friedman JM; Nosanchuk JD; Martinez LR
Am J Pathol; 2012 Apr; 180(4):1465-73. PubMed ID: 22306734
[TBL] [Abstract][Full Text] [Related]
13. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.
Lodise TP; Miller CD; Graves J; Furuno JP; McGregor JC; Lomaestro B; Graffunder E; McNutt LA
Antimicrob Agents Chemother; 2007 Feb; 51(2):417-22. PubMed ID: 17158943
[TBL] [Abstract][Full Text] [Related]
14. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
Miyajima Y; Hiramatsu K; Mizukami E; Morinaga R; Ishii H; Shirai R; Kishi K; Tokimatsu I; Saikawa T; Kadota J
Int J Antimicrob Agents; 2008 Nov; 32(5):437-40. PubMed ID: 18715759
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model.
Trøstrup H; Thomsen K; Christophersen LJ; Hougen HP; Bjarnsholt T; Jensen PØ; Kirkby N; Calum H; Høiby N; Moser C
Wound Repair Regen; 2013; 21(2):292-9. PubMed ID: 23437978
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide releasing two-part creams containing S-nitrosoglutathione and zinc oxide for potential topical antimicrobial applications.
Doverspike JC; Zhou Y; Wu J; Tan X; Xi C; Meyerhoff ME
Nitric Oxide; 2019 Sep; 90():1-9. PubMed ID: 31170453
[TBL] [Abstract][Full Text] [Related]
18. Activity of a nitric oxide-generating wound treatment system against wound pathogen biofilms.
Waite RD; Stewart JE; Stephen AS; Allaker RP
Int J Antimicrob Agents; 2018 Sep; 52(3):338-343. PubMed ID: 29665443
[TBL] [Abstract][Full Text] [Related]
19. Topical Application of Cinnamaldehyde Promotes Faster Healing of Skin Wounds Infected with
Ferro TAF; Souza EB; Suarez MAM; Rodrigues JFS; Pereira DMS; Mendes SJF; Gonzaga LF; Machado MCAM; Bomfim MRQ; Calixto JB; Arbiser JL; Monteiro-Neto V; André E; Fernandes ES
Molecules; 2019 Apr; 24(8):. PubMed ID: 31027179
[TBL] [Abstract][Full Text] [Related]
20. S-Nitrosoglutathione loaded poly(lactic-co-glycolic acid) microparticles for prolonged nitric oxide release and enhanced healing of methicillin-resistant Staphylococcus aureus-infected wounds.
Hlaing SP; Kim J; Lee J; Hasan N; Cao J; Naeem M; Lee EH; Shin JH; Jung Y; Lee BL; Jhun BH; Yoo JW
Eur J Pharm Biopharm; 2018 Nov; 132():94-102. PubMed ID: 30223029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
